Characterisation and use of OSLD for in vivo dosimetry in head and neck intensity-modulated radiation therapy. Issue 4 (25th December 2021)

• Record Type: Journal Article
• Authors: Raj, L. Jose Solomon; Pearlin, Benedicta; Peace, B. S. Timothy; Isiah, Rajesh; Singh, I. Rabi Raja
• Is Part Of: Journal of radiotherapy in practice. Volume 20:Issue 4(2021)
• Page Start: 448
• Page End: 454
• Publication Date: 2021-12-25
• Subjects: optically stimulated luminescence dosimeter -- in vivo dosimetry -- intensity modulated radiation therapy; Radiotherapy -- Periodicals; 615.842005
• DOI: 10.1017/S146039692000062X
• Languages: English
• ISSNs: 1460-3969

Abstract

Abstract: Aim: This study reveals the characteristic nature and the use of optically stimulated luminescence dosimeters (OSLD) as an in vivo dosimetry tool for head and neck intensity-modulated radiation therapy (IMRT). Materials and methods: Calibration and characterisation of OSLD such as sensitivity, reproducibility, dose-rate dependence, beam quality dependence, output factor measurement and comparison of two bleaching techniques using halogen and compact fluorescent lamp (CFL) were initially performed. Later, eye dose measurements were performed for head and neck IMRT patients using OSLD and were compared with the corresponding dose calculated by the treatment planning system (TPS). Results: While the sensitivity was found to be within ±5%, the dose-rate dependence and reproducibility were found to be within ±3%. The OSLD showed an under-response of 3% for 15 MV and an increase in response by 5% for Co 60 (1·25 MeV) when compared with the 6 MV X-ray beam. Therefore, a separate calibration for different beam energies is required. The percentage deviation of OSLD to that of TPS was found to be within ±2·77%. The OSLD has been successfully used for the in vivo dosimetry of patients who received IMRT. Hence, it is concluded that OSLDs can serve as effective dosimeters for in vivo dosimetry.